SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

54 Southeastern European Medical Journal, 2022; 6(2) 
 

Original article 

Comorbidity of Somatic Illnesses on People With Treated Mental 
Disorders – A New Challenge in Medicine 1 

Romana Marušić 1,2, Adriana Levaković 2, Dunja Degmečić 2,3, Tatjana Bačun 2,4* 

1 Department of Internal Medicine, National Memorial Hospital Vukovar, Croatia 
2 Faculty of Medicine, J.J. Strossmayer University, Osijek, Croatia 
3 Department of Psychiatry, University Hospital Centre, Osijek, Croatia 
4 Division of Endocrinology, Department of Internal Medicine, University Hospital Centre, Osijek; Croatia 

 

 

*Corresponding author: Tatjana Bačun, tbacun@gmail.com 

 

Received: Apr 12, 2022; revised version accepted: Oct 20, 2022; published: Nov 28, 2022 
  
KEYWORDS: chronic diseases, comorbidity, mental disorders  
 

Abstract 
Aim. Comorbidities pose a major challenge for 21st century medicine. The mutual pathophysiological 
effect of one disease on another can significantly affect their course and prognosis. The aims of this 
study were to examine the frequency of comorbidities and the most common psychiatric and 
somatic comorbidities and to determine the difference in the incidence of certain diseases by gender 
and age. 
Methods. Data were recorded in several groups: demographic characteristics, psychiatric and 
somatic diagnoses classified according to gender, age, and the legally determined ability to work, 
and correlations of somatic and psychiatric diagnoses.  
Results. The most common psychiatric diagnoses in men were post-traumatic stress disorder (PTSD) 
(25%) and alcoholism (23%), while in women these were recurrent depressive disorder (19%) and 
psychosis (10%). A statistically significant difference was found in the incidence of alcoholism and 
PTSD, which are more common in men than in women. The most common somatic diseases in both 
sexes were arterial hypertension (M = 33%, F = 46%) and diabetes mellitus (M = 18%, F = 32%). 
Statistically significant differences were found in the frequency of hypertension (p = 0.03) and 
epilepsy (p = 0.002), which are more common in men. The ratio alcoholism-hypertension (p = 0.03), 
alcoholism-diabetes (p < 0.0001), alcoholism-COPD (p < 0.001) was statistically significant.  
Conclusion. It is extremely important to improve the multidisciplinary approach and cooperation in 
treatment in order to reduce the number of hospitalizations, emergency interventions and suicides 
and to improve the patients’ quality of life and life expectancy. 
 

(Marušić R, Levaković A, Degmečić D, Bačun T*. Comorbidity of Somatic Illnesses on People With 
Treated Mental Disorders – A New Challenge in Medicine. SEEMEDJ 2022; 6(2); 54-66) 

 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

55 Southeastern European Medical Journal, 2022; 6(2) 
 

Introduction 

Comorbidity indicates the presence of two or 
more different diseases or disorders 
simultaneously and poses a major challenge for 
21st century medicine (1). People with a chronic 
physical illness are 1.5 to 2 times more likely to 
develop a mental disorder (2). 

It is estimated that 25% of the general population 
has some form of mental disorder. Of these, as 
many as 68% have one or more physical 
comorbidities (3). Due to the extended average 
lifespan, the prevalence of multimorbidity is 
increasing; in Australia, it is 75% for people aged 
65 to 74 and over 80% for people aged 75 and 
above. A study conducted in Ontario showed a 
multimorbidity of 7 to 35 % in people between 
the ages of 18 and 65 (4). In Croatia, the 
prevalence of multimorbidity is 79.8 % for people 
over 65 (5).  

Mental disorders are a major public health 
problem that has a significant impact on the 
health of people with chronic diseases and can 
change the course of their illness and their 
prognosis. Depression is present in 40% of 
people with hypertension; the prevalence is 
36.6% in men and as much as 63.4% in women. In 
somatically healthy individuals with depressive 
disorder, the risk of coronary heart disease is 
increased 1.5- to 2-fold, while in individuals with 
coronary heart disease, the risk of myocardial 
infarction is increased 1.5- to 4.5-fold (2). Some 
studies show that the prevalence of depressive 
disorders in people with diabetes ranges from 8 
to 15% (6). Only 25% to 50% of people with 
diabetes who suffer from depression get 
diagnosed and treated (7). The risk of 
complications of the disease is increased as 
much as 4 times due to the reduced ability to 
regulate glucose metabolism (1, 8). Other studies 
show that as many as 47.6% of young people 
with insulin-dependent diabetes develop a 
mental disorder after ten years, most often one 
year after diagnosis (2). 

The cost of hospital treatment of patients with 
comorbid depression was increased 1.5-fold 
compared with other patients. The positive 

correlation of psychological comorbidities with 
the length of hospital stays, doctor visits, and 
longer  sick leave has also been proven, which 
leads to a reduced quality of life and higher 
treatment costs (2).  One study showed that 
every fifth person in physical rehabilitation 
suffers from a comorbid mental disorder. This 
has an adverse effect on the outcome of 
rehabilitation due to the patient’s reduced 
motivation, cooperation, and active participation 
in the rehabilitation process (9). 

Due to the high incidence of comorbidities of 
physical and mental illnesses, it is important to 
conduct preventive examinations, personalized 
pharmacotherapy and psychotherapy, and 
educational programs for medical professionals. 
An integrative approach and timely recognition 
and treatment can reduce mortality, morbidity, 
and overall treatment costs (10). 

The aims of our research were to examine the 
frequency of comorbidities and the most 
common psychiatric and somatic comorbidities 
and to determine the difference in the incidence 
of certain diseases by gender and age. 

Patients and methods 

Patients and study design 

The research was organized as a cross-sectional 
study with historical data. It was approved by 

the Ethics Committee of the Faculty of Medicine 
Osijek, Josip Juraj Strossmayer University 

in Osijek. The study was conducted on 137 
subjects who were hospitalized at the Clinic for 
Psychiatry of the Clinical Hospital Center Osijek. 
Data were collected from the hospital 
information system of the Clinical Hospital 
Center Osijek over a period of one year. Inclusion 
criterion was diagnosis of any somatic illness in 
psychiatric patients. 

Methods 

Data were categorized in several groups: 
demographic characteristics of respondents, 
psychiatric and somatic diagnoses classified 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

56 Southeastern European Medical Journal, 2022; 6(2) 
 

according to gender, age, and the legally 
determined ability to work (up to 65 years), and 
correlations of somatic and psychiatric 
diagnoses. To examine the correlation between 
somatic and psychiatric diagnoses, only 
diagnoses for which frequency was higher than 
3% (N ≥ 7 for psychiatric, N ≥ 5 for somatic 
diagnoses) in total population and somatic 
diagnoses that are applicable in both genders 
came into consideration. 

Statistical analysis 

R software was used to perform statistical 
analysis of the collected data. Descriptive data 
are expressed in frequency and share for 
nominal variables and arithmetic and standard 
deviation for numerical variables that have a 
normal distribution. The normality of distribution 
was examined using the Kolmogorov-Smirnov 
test. Differences of category variables were 
tested by binomial, χ2, and Fisher’s exact test, 

and the degree of correlation was examined by 
the φ test. Differences of numerical variables 
with normal distribution were tested by 
Student’s t-test. The level of statistical 
significance was set at p < 0.05. 

Results 

The study included 137 respondents, of whom 
95 (70%) were men and 42 (30%) were women. 
The mean age of men was 55.9 ± 12.1 (22 to 87) 
and women 56.9 ± 13.5 (16 to 80). Of the 137 
respondents, 2% were aged between 18 and 30, 
76% were between 30 and 65, and 23% were 
over 65. A statistically significant difference was 
found in the number of respondents by sex, in 
the group aged 35 to 65 years (p < 0.0001). 
Respondents were divided according to 
employment into employed, unemployed, and 
retired ones: A statistically significant difference 
was found between retired men and women (p 
< 0.0001) (Table 1). 

Table 1. Demographic characteristics of respondents 
 

   
  Male Female Total p   

Age 55.9+12,2 56.9+13,5   0.68   

Age category           

16-30 2(20%) 1(2%) 3(2%) 0.56   

30-65 73(77%) 30(71%) 103(76%) < 0.0001 

  

65 + 20(20%) 11(26%) 31(23%) 0.15 

Employment status         

         Employed 15(16%) 3(7%)  18(13%) < 0.05 

         Unemployed 22(23%) 16(39%) 38(28%) 0.41 

         Retired 57(60%) 22(54%) 79(59%) < 0.0001 

 
 

The most common psychiatric diagnoses in men 
were post-traumatic stress disorder (PTSD) 
(25%), alcoholism (23%), recurrent depressive 
disorder (13%), while in women the most 
common ones were recurrent depressive 
disorder (19%), psychosis (10%), alcoholism, 

PTSD, and anxiety-depressive disorder (7%). A 
statistically significant difference was found in 
the incidence of alcoholism and PTSD, which 
were more common in men than in women 
(Table 2).

 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

57 Southeastern European Medical Journal, 2022; 6(2) 
 

Table 2. Psychiatric diagnoses of respondents 
  Male Female Total p   

Alcoholism 33(23%) 4(7%) 37(18%) < 0.0001 

  

Recurrent depressive disorder 18(13% 11(19%) 29(14%) 0.26 

PTSD* 35(25%) 4(7%) 39(19%) < 0.0001 

Psychoorganic syndrome 7(5%) 2(3%) 9(4%) 0.18 

Anxiety-depressive disorder 3(2%) 4(7%) 7(3%) 1 

Psychosis 8(6%) 6(10%) 14(7%) 0.79 

Another inorganic psychotic disorder 1(1%) 0(0%) 1(0%)   

Pervasive developmental disorder 0(0%) 1(2%) 1(0%)     

Mild mental retardation 4(3%) 1(2%) 5(2%) 0,27   

Delirium tremens 3(2%) 0(0%) 3(1%)   

  

Organic insane disorder 1(1%) 3(5%) 4(2%) 0,62 

Schizophrenia 6(4%) 3(5%) 9(4%) 0.5 

Borderline depressive decompensation 4(3%) 3(5%)  7(3%) 1 

Depressive disorder 10(7%) 3(5%) 13(6%) 0.09 

Bipolar affective disorder 2(1%) 4(7%) 6(3%) 0.68 

Crisis  1(1%) 4(7%) 5(2%) 0.37 

OCD* 3(2%) 0(0%) 3(1%)   

Schizoaffective disorder 2(1%) 3(5%) 5(2%) 1 

Organic emotionally labile disorder 0(0%) 3(5%) 3(1%)   

Anorexia nervosa 1(1%) 0(0%) 1(0%)   

*PTSD – Post-traumatic stress disorder, OCD – Obsessive-compulsive disorder 

 

Of the somatic diagnoses, the most common 
diagnoses in both sexes were arterial 
hypertension (M = 33%, F = 46%), diabetes 
mellitus (M = 18%, F = 32%) and epilepsy (M = 15%, 

F = 8%). Statistically significant differences were 
found in the frequency of arterial hypertension 
(p = 0.03) and epilepsy (p = 0.002), which were 
more common in men (Table 3).



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

58 Southeastern European Medical Journal, 2022; 6(2) 
 

   Table 3. Somatic diagnoses of respondents 
  Male Female Total p   

Arterial hypertension 41(33%) 23(46%) 64(36%) 0.03 

  

Diabetes mellitus 23(18%) 16(32%) 39(22%) 0.34 

Epilepsy 19(15%) 4(8%) 23(13%) 0.002 

COPD* 5(4%) 2(4%) 7(4%) 0.45 

Liver cirrhosis 1(1%) 0(0%) 1(1%)   

Gastric ulcer 2(2%) 0(0%) 2(1%)   

Pneumonia 2(2%) 0(0%) 2(1%)   

Hashimoto's thyroiditis 0(0%) 1(2%) 1(1%)     

Multiple sclerosis 1(1%) 0(0%) 1(1%)     

Lumbosacral pain 2(2%) 0(0%) 2(1%)   

  

Esophagitis 0(0%) 0(0%) 0(0%)   

Chronic gastritis 5(4%) 0(0%) 5(3%)   

Venous ulcer 1(1%) 0(0%)  1(1%)   

Pulmonary embolism 0(0%) 1(2%) 1(1%)   

NHL* 1(1%) 0(0%) 1(1%)   

Angina pectoris 3(2%) 0(0%) 3(2%)   

Esophageal cancer 1(1%) 0(0%) 1(1%)   

Psoriasis 4(3%) 0(0%) 4(2%) 1 

Prostate hyperplasia 5(4%) 0(0%) 5(3%)   

Parkinson’s disease 3(2%) 0(0%) 3(2%)  

Acute renal failure 1(1%) 0(0%) 1(1%)   

Cystitis 1(1%) 0(0%) 1(1%)   

Hepatitis 1(1%) 0(0%) 1(1%)   

Cervicobrachial syndrome 0(0%) 1(2%) 1(1%)   

GERD* 1(1%) 0(0%) 1(1%)   

SLE* 0(0%) 2(4%) 2(1%)   

Urine retention 1(1%) 0(0%) 1(1%)  

Hodgkin’s disease 1(1%) 0(0%) 1(1%)  

*COPD – Chronic obstructive pulmonary disease, NHL – Non-Hodgkin's lymphoma, GERD – Gastroesophageal reflux disease, 

SLE – Systemic lupus erythematosus 

Since we were interested in the frequency of 
psychiatric diagnoses among respondents, we 
divided them into groups based on their 
employment status and age. The most common 
illness-related psychiatric diagnoses among 
retired respondents were recurrent depressive 

disorder (31%), PTSD (26%), and alcoholism (12%). 
Unemployed respondents were most often 
diagnosed with alcoholism (25%), recurrent 
depressive disorder (16%), and PTSD (14%). 
Similar diagnoses were most common among 
employed respondents: alcoholism (33%) and 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

59 Southeastern European Medical Journal, 2022; 6(2) 
 

PTSD (11%). χ2 showed a significant statistical 
difference in the number of patients with PTSD 
and recurrent depressive disorder among 

retired, unemployed, and employed 
respondents under the age of 65 (Table 4). 

 

Table 4. Psychiatric diagnoses according to the employment status 

  Retired   Unemployed Employed   

  > 65 < 65 > 65 < 65 p 

Alcoholism 5(12%) 10(12%) 13(25%) 9(33%) 0.8 

Psychosis 5(12%) 0(0%) 4(8%) 2(7%)   

PTSD* 2(5%) 21(26%) 7(14%) 3(11%) 0.0004 

Schizophrenia 2(5%) 5(16%) 2(4%) 0(0%)   

Borderline depressive decompensation 0(0%) 3(4%) 2(4%) 2(7%) 0.98 

Depressive disorder 5(12%) 2(2%) 5(10%) 2(7%) 0.63 

Bipolar affective disorder 0(0%) 4(5%) 1(2%) 1(4%) 0.5 

Mixed anxiety-depressive disorder 0(0%) 3(4%) 3(6%) 1(4%) 0.85 

Recurrent depressive disorder 5(12%) 25(31%) 8(16%) 2(7%) < 0.0001 

Organic emotionally labile disorder 3(7%) 0(0%) 0(0%) 0(0%)   

Mild mental retardation 0(0%) 2(2%) 0(0%) 1(4%)   

Crisis 1(2%) 1(1%)  1(2%) 287%) 0.96 

Psychoorganic syndrome 10(24%) 5(6%) 0(0%) 0(0%)   

Organic delusional disorder 2(5%) 0(0%) 1(1%) 1(4%)   

Anorexia nervosa 0(0%) 0(0%) 1(2%) 0(0%)   

Schizoaffective disorder 0(0%) 0(0%) 4(8%) 0(0%)   

Pervasive developmental disorder 0(0%) 0(0%) 0(0%) 0(0%)   

Delirium tremens 1(2%) 0(0%) 0(0%) 1(4%)   

OCD* 0(0%) 0(0%) 0(0%) 0(0%)   

            
*PTSD – Post-traumatic stress disorder, OCD – Obsessive-compulsive disorder 

 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

60 Southeastern European Medical Journal, 2022; 6(2) 
 

 

Figure 1. Correlation of somatic and psychiatric diagnoses 
* PTSD – Post-traumatic stress disorder, COPD – Chronic obstructive pulmonary disease 
 

With the aim of roughly determining the 
correlation of somatic and psychiatric 
diagnoses, a graph was made to reflect that 
correlation (Figure 1). 

We took the most significant diagnoses from the 
graph and made a matrix in which we tested the 
statistical significance and correlation of the 
most common diagnoses:  

1. Psychiatric diagnoses: alcoholism, recurrent 
depressive disorder, PTSD, mixed anxiety-
depressive disorder, schizophrenia, depressive 
disorder 

2. Somatic diagnoses: hypertension, diabetes 
mellitus, epilepsy, COPD, gastritis. 

The ratios alcoholism-hypertension (p = 0.03), 
alcoholism-diabetes mellitus (p < 0.0001), 
alcoholism-COPD (p < 0.001) were statistically 
significant, which means that respondents 
treated for alcoholism had a lower risk for 
hypertension, diabetes, and COPD, although the 
correlation was almost equal to zero (Φ1 = 0.03, 
Φ2 = 0, Φ3 = 0.004) (Table 5). 

 

 

0

5

10

15

20

25

Hypertension Diabetes mellitus Epilepsy COPD Gastritis



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

61 Southeastern European Medical Journal, 2022; 6(2) 
 

Table 5. Correlation of somatic and psychiatric disorders 

 
       HYPERTENSION   DIABETES MELLITUS   EPILEPSY     COPD     GASTRITIS 

    
Yes No p φ   Yes No p φ Yes No p φ   Yes No p Φ   Yes No p 

  Yes        12 25    5 32   14 23    1 36    2 35   

Alcoholism    0.03 0.03   
<0.000
1 0.18 0.18    

<0.00
1 0.004    

0.6
2 

  No 52 45    59 38   50 47    6 92    1 94   
                          

Recurrent Yes 15 14    8 21   1 28    3 26    2 27   

depressive    0.678    1    0.03 0.03  0.17     0.3 

disorder No 49 56    31 74   22 83    4 
10

1    3 102   
                          

  Yes 20 19    12 27   5 34    3 36    2 37   

PTSD    0.7     0.84    0.46    0.41     0.63 

  No 44 51    27 68   18 77    4 91    3 92   

                        
Psychoorga
nic  Yes 6 3    4 5   1 8    0 9    1 8  

syndrome    0.31     0.45    1          0.29 

 No 58 67    35 90   22 103    7 
11
8    4 121  

                          
Mixed 
anxiety- Yes 5 2    4 3   0 7    1 6    0 7   
depressive    0.26     0.19         0.32       

disorder No 59 68    35 92   23 
10
4    6 

12
1    5 122   

                          

  Yes 5 4    3 6   1 8    0 9    0 9   

Psychosis    0.74     0.72    1            

  No 59 66    36 89   22 
10

3    7 
11
8    5 120   

                          
  Yes 2 6    3 5   1 7    1 7    0 8   
Schizophren
ia    0.28     0.69    1     0.36       

  No 62 64    36 90   22 
10
4    6 

12
0    5 121   

Borderline Yes 4 3    1 6   1 6    2 6    0 7   

depressive    0.7     0.67    1     0.056       
decompens
ation No 60 67    38 89   22 

10
5    5 

12
1    5 122   

                          

Depressive Yes 8 4     2 10   2 10    1 11    0 12   

disorder     0.23     0.5    1     0.49      

 No 56 66    37 85   21 
10

1    6 
11
6    5 117   

Bipolar Yes 2 4    2 4   2 4    0 6    0 6   

affective    0.69     1    0.27           

disorder No 62 66       37 91     21 
10

7       7 
12

1       5 123   

* PTSD – Post-traumatic stress disorder, COPD – Chronic obstructive pulmonary disease 

 

Discussion 

Comorbidities of physical and mental disorders 
occur with high frequency, and they are most 
often present in people over 65 years of age. In 
this study, a statistically significant difference 
was found in the incidence of PTSD and 
alcoholism in men and women; they were 
significantly more common in men, while 

recurrent depressive disorder was more 
common in women. 

In our research, PTSD is almost four times more 
common in men. It is estimated that 3 to 6% of 
the population suffers from PTSD. Seeing as 
some studies show that about 49.8% of people 
who were in the war develop PTSD, these 
findings can be related to the Croatian War of 
Independence in the early 1990s. PTSD was 
most often diagnosed in retired respondents 
under the age of 65 (26% of respondents), which 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

62 Southeastern European Medical Journal, 2022; 6(2) 
 

we can also attribute to the recent Croatian war 
history. Although several studies show 
increased incidence of somatic diseases in 
patients who suffer from PTSD, our study did not 
show a statistically significant correlation 
between PTSD and certain somatic diseases (11, 
12, 13). One of the possible reasons could be a 
small number of participants in our study. PTSD 
is often associated with physical comorbidities 
ranging from nonspecific dizziness, tinnitus, and 
blurred vision to chronic pain, diabetes, 
cardiovascular, respiratory, and gastrointestinal 
diseases. There is also increased risk of cancer, 
arthritis, autoimmune and inflammatory 
diseases. In our study, the most common 
somatic disease in patients with PTSD was 
hypertension. A high ratio of patients with PTSD 
have unhealthy lifestyles and habits such as 
heavy smoking, low physical activity, and 
obesity, which lead to development of vascular, 
degenerative, and other types of somatic 
disorders (14).  As many as 80% of people have 
at least one mental disorder with PTSD, the most 
common being depressive disorder, generalized 
anxiety disorder, and addictive disorder. Due to 
non-cooperation, the frequency of 
hospitalizations and relapses is high (15). 
Therefore, it is important to identify individuals 
suffering from this disease, encourage them to 
cope with the problem, and take care of their 
mental and physical health to avoid further 
consequences and comorbidities (16). 

In our study, the most common mental disorder 
in women was recurrent depressive disorder 
(19%). The most common comorbidity with a 
recurrent depressive disorder was hypertension 
(4). Studies have shown that individuals with 
depression are more likely to develop 
hypertension, strokes, and ischemic heart 
disease. There is a pathophysiological 
connection between depression and 
hypertension because both disorders are 
characterized by increased sympathetic tone 
and increased secretion of adrenocorticotropic 
hormone and cortisol. Moreover, depressed 
patients may have difficulty adhering to their 
therapy regimen, resulting in poor blood 
pressure control (17). The prevalence of 
depression is 10 to 15%, with over 350 million 

people currently affected. Risk factors for 
developing depression disorder include 
stressful events, genetic predisposition, 
disability, illness, previous treatment for 
depression disorder and sleep problems. 
Somatic chronic diseases increase the risk of 
developing depression due to reduced quality 
of life, difficulty coping with diagnosis, pain, and 
rejection of the environment (4). Also, the 
prevalence of depression in people who suffer 
from at least one chronic illness is 9.3 to 23% and 
differs greatly from people who do not suffer 
from any chronic disorder (3.2 %). Increased 
prevalence of depressive disorders has been 
noticed in people suffering from cardiovascular 
diseases (17-27%), diabetes (11-31%), and arthritis 
(10-24%) (4, 17). 

In this research, 25% of men and 7% of women 
were treated for alcoholism. It is estimated that 
43% of the world's population consumes alcohol 
(18). In Croatia, about 6% of the population 
suffers from alcohol dependence, which 
amounts to about 250,000 people (19). Spirits 
(44.8 %) and beer (34.3 %) are most often 
consumed. Alcoholism is twice as common in 
men than in women, with the highest frequency 
between the ages of 20 and 24 (18). Alcoholics 
have twice the risk of developing other mental 
illnesses; these are most often anxiety disorders, 
affective disorders, personality disorders. 
Psychiatric disorders are thought to precede the 
development of alcoholism, except for 
obsessive-compulsive disorder and depression, 
which occur after alcohol use disorder (20). In 
addition, there is also a great link with various 
physical comorbidities.  

In our study, the most common somatic 
diseases in patients treated for alcoholism were 
epilepsy and hypertension. Alcohol has a 
significant effect on the central nervous system, 
leading to symptoms of mania, depression, and 
epileptic seizures. Chronic alcohol consumption 
is related to multiple central and peripheral 
nervous system dysfunctions due to the direct 
action of alcohol or its derivatives and vitamin 
deficiencies associated with alcoholism (21). 
According to data from 2012, alcohol 
consumption was associated with 5.5% of 
cancers (7.2% in men and 3.5% in women) and 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

63 Southeastern European Medical Journal, 2022; 6(2) 
 

with 5.8% of deaths in oncological patients (22). 
The most common cancers associated with 
alcohol use are cancers of the oral cavity, 
pharynx, larynx, esophagus, liver, breast, and 
colon. The carcinogenic potential is linearly 
dependent on the amount of consumed alcohol 
(23). Alcohol consumption has a dual effect on 
the cardiovascular system; it has a 
cardioprotective effect in small doses (one 
standard drink), but it is harmful in large doses 
(24). The consumption of two standard drinks is 
considered to have a protective effect in 
diabetes mellitus but consuming four standard 
drinks a day results in negative effects. Since 
most of the alcohol is metabolized in the liver, 
liver diseases are not uncommon; chronic liver 
diseases that lead to cirrhosis are the most often 
(25). Primary alcoholic dementia accounts for 
10% of all dementias (26). 

Arterial hypertension is the most common 
somatic disease in this study. It affected 33% of 
men and 46% of women, a total of 36% of the 
respondents. Hypertension and coronary heart 
disease cause significant morbidity in patients, 
reduce the quality of life, and increase treatment 
costs. Psychosocial factors that lead to anxiety 
disorders play a role in the development of 
hypertension. Increased autonomic excitation 
via the hypothalamic-pituitary axis leads to an 
increase in circulating catecholamines, which 
increases the risk of hypertension and 
proinflammatory conditions, which in turn leads 
to the development of coronary heart disease 
(27). Also, hypertension intensifies symptoms of 
anxiety and the frequency of panic attacks. In 
one study, a significantly higher incidence of 
panic attacks was noticed in patients with 
hypertension (17%) compared to normotensive 
patients (11%) (28). Other anxiety disorders are 
also common; monitoring cardiac activity or 
avoiding certain activities often results in 
reduced quality of life in patients with 
hypertension (29). 

Diabetes mellitus is the second most common 
somatic diagnosis in our respondents (22%). We 
found a higher incidence in women (32%) than in 
men (18%). 30% of patients with diabetes suffer 
from a mental disorder. Patients with 
schizophrenia are two to four times more likely 

to develop diabetes compared to the general 
population (30). The prevalence rates of 
depression and anxiety are significantly higher in 
diabetics; some studies have reported that the 
risk is increased by as much as 50-100%. The 
correlation is two-way, depression disorder 
results from years of uncontrolled or poorly 
controlled diabetes. Depression disorder, on the 
other hand, activates neurohormonal and 
neurotransmitter changes that stimulate the 
hypothalamic-pituitary axis and the adrenal 
gland, which releases more cortisol and other 
hormones responsible for insulin resistance (30, 
31). The prevalence of diabetes in depressed 
adult patients is significantly higher in women 
than in men. A study conducted in Saudi Arabia 
reported that 37% of patients with type 1 
diabetes mellitus, 37.9% of patients with type 2 
diabetes mellitus, and 13.6% of patients with 
gestational diabetes suffer from depression. 
Another study reported that 46.15% of patients 
have these comorbidities, of which 36.7% suffer 
from severe depression. What is more, levels of 
glycosylated hemoglobin (HbA1c) are 
significantly higher in people with depression 
compared with those who do not suffer from it 
(30). 

Epilepsy affected 15% of men and 8% of women, 
a total of 13% of respondents. It is estimated that 
the most common mental illness in comorbidity 
with epilepsy is depression, and its incidence is 
about 35%. In patients in whom epilepsy is poorly 
controlled, the incidence is about 50%, while in 
patients with well-controlled seizures it is about 
10 to 20% (31). One study showed that 16.7% of 
patients with epilepsy have some sort of anxiety 
disorder; most people had frequent panic 
attacks (81.2%). Older age of patients and later 
onset of epileptic seizures are associated with a 
higher incidence of anxiety disorders (32). 

Comorbidities of physical and mental illnesses 
are a major challenge in medicine. The mutual 
pathophysiological effect of one disease on 
another can significantly affect the course and 
prognosis of the disease. Due to the diverse 
symptoms experienced by people with 
multimorbidity, diagnoses are often missed, 
which can lead to major consequences. It is 
extremely important to improve cooperation in 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

64 Southeastern European Medical Journal, 2022; 6(2) 
 

treatment and the multidisciplinary approach to 
the patient in order to reduce the number of 
hospitalizations, emergency interventions, 
suicides and improve the patients’ quality of life 
and life expectancy. 

Acknowledgement. None. 

Disclosure 
Funding. No specific funding was received for 
this study. 
Competing interests.  None to declare. 
 
 

References 

1. Sartorius N. Comorbidity of mental and 
physical disorders: a key problem for 
medicine in the 21st century. Acta 
Psychiatrica Scandinavica 2018; 
137(5):369-370. 
 

2. Klesse C, Baumeister H, Bengel J, Härter 
M. Somatische und psychische 
Komorbidität. Psychotherapeut 2008; 
53:49–62. 
 

3. Šprah L, Dernovšek MZ, Wahlbeck K, 
Haaramo P. Psychiatric readmissions and 
their association with physical 
comorbidity: a systematic literature 
review. BMC Psychiatry 2017; 17(1):2.  
 

4. Read JR, Sharpe L, Modini M, Dear BF. 
Multimorbidity and depression: A 
systematic review and meta-analysis. J 
Affect Disord 2017; 221:36-46. 
 

5. Kašuba Lazić Đ, Cedilnik Gorup E. 
Bolesnik s istodobnim bolestima u 
obiteljskoj medicini. U: Katić M, Švab I i 
sur: Obiteljska medicina. Zagreb: Alfa 
Zagreb, 2013; 391-400. 
 

6. Engidaw, N.A., Wubetu, A.D. & Basha, E.A. 
Prevalence of depression and its 
associated factors among patients with 
diabetes mellitus at Tirunesh-Beijing 
general hospital, Addis Ababa, Ethiopia. 
BMC Public Health. 2020:266. 
 
 

7. Bădescu SV, Tătaru C, Kobylinska L, 
Georgescu EL, Zahiu DM, Zăgrean AM, 
Zăgrean L. The association between 

Diabetes mellitus and Depression. J Med 
Life. 2016; 9(2):120-5. 
 

8. Zhang Y, Chen Y, Ma L. Depression and 
cardiovascular disease in elderly: Current 
understanding. J Clin Neurosci 2018; 47:1-
5. 
 

9. Härter M, Baumeister H, Bengel J, eds. 
Psychische Störungen bei körperlichen 
Erkrankungen. Berlin: Springer, 2007. 
 
 

10. Filipčić I, Šimunović Filipčić I. Psihički 
poremećaji i tjelesne bolesti. Medicus 
2017; 26 (2 Psihijatrija danas):205-208. 
 

11. von Känel R, Begré S, Abbas CC, Gander 
ML, Schmid JP. Inflammatory Biomarkers 
in Patients with Posttraumatic Stress 
Disorder Caused by Myocardial Infarction 
and the Role of Depressive Symptoms. 
Neuroimmunomodulation, 2010; 17: 39-
46.   
 

12. van Kamp I, van der Velden PG, Stellato 
RK et. al. Physical and mental health 
shortly after a disaster: first results from 
the Enschede firework disaster study. Eur 
J Public Health, 2006; 16(3): 253-9.   
 

13. Fischer CJ, Struwe J, Lemke MR. 
Longterm effect of traumatic 
experiences on somatic and psychic 
complaints of German World War Two 
refugees. Nervenartz, 2006; 77(1): 58-63. 
 
 

14. Kadoic D, Obradovic M, Čandrilic M, 
Filakovic P. Neurobiological and clinicla 
consequences of posttraumatic stress 
disorder. Acta Clin Croat, 2000; 39: 89-94. 
 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

65 Southeastern European Medical Journal, 2022; 6(2) 
 

15. Mímica N, Uzun S, Kozumplik O, Žakić 
Milas D, Glavina T. Psihometrijski i klinički 
instrumenti za procjenu posttraumatskog 
stresnog poremećaja i ocjenu terapijskog 
učinka. Medicina Fluminensis 2018; 
54(2):155-165. 
 

16. Naguy A, Alamiri B. PTSD - Inevitable or 
preventable? Australas Psychiatry 2018; 
26(6):670. 
 

17. Rubio-Guerra AF, Rodriguez-Lopez L, 
Vargas-Ayala G, Huerta-Ramirez S, Serna 
DC, Lozano-Nuevo JJ. Depression 
increases the risk for uncontrolled 
hypertension. Exp Clin Cardiol. 2013 
Winter; 18(1):10-2. 
 

18. World Health Organization. Global status 
report on alcohol and health 2018. 
https://apps.who.int/iris/handle/10665
/274603 (07 December 2021). 
 

19. Rapić M, Vrcić Keglević M. 
ALKOHOLIZAM – ZABORAVLJENA 
DIJAGNOZA U OBITELJSKOJ MEDICINI. 
Medicina familiaris Croatica 2014; 
22(2):25-32. 
 

20. Powell BJ, Penick EC, Othmer E, Bingham 
SF, Rice AS. Prevalence of additional 
psychiatric syndromes among male 
alcoholics. J Clin Psychiatry 1982; 
43(10):404-407. 
 

21. Fouarge E, Maquet P. Conséquences 
neurologiques centrales et périphériques 
de l’alcoolisme [Neurological 
consequences of alcoholism]. Rev Med 
Liege. 2019; 74(5-6):310-313. 
 

22. Praud D, Rota M, Rehm J, Shield K, 
Zatoński W, Hashibe M, La Vecchia C, 
Boffetta P. Cancer incidence and 
mortality attributable to alcohol 
consumption. Int J Cancer 2016;  
15;138(6):1380-7.  
 
 

23.  Scoccianti C, Cecchini M, Anderson AS, 
Berrino F, Boutron-Ruault MC, Espina C, 
Key TJ, Leitzmann M, Norat T, Powers H, 
Wiseman M, Romieu I. European Code 
against Cancer 4th Edition: Alcohol 
drinking and cancer. Cancer Epidemiol 
2016; 45:181-188.  
 

24. O'Keefe JH, Bybee KA, Lavie CJ. Alcohol 
and cardiovascular health: the razor-
sharp double-edged sword. J Am Coll 
Cardiol 2007; 50(11):1009-14. 
 

25. Bruha R, Dvorak K, Petrtyl J. Alcoholic 
liver disease. World J Hepatol 2012; 
4(3):81–90. 
 

26. Gupta S, Warner J. Alcohol-related 
dementia: A 21st-century silent 
epidemic? Br J Psychiatry 2008; 
193(5):351–3. 
 

27. Player MS, Peterson LE. Anxiety 
disorders, hypertension, and 
cardiovascular risk: a review. Int J 
Psychiatry Med 2011; 41(4):365-77. 
 

28. Davies SJ, Ghahramani P, Jackson PR, 
Noble TW, Hardy PG, Hippisley-Cox J, 
Yeo WW, Ramsay LE. Association of 
panic disorder and panic attacks with 
hypertension. Am J Med 1999; 107(4):310-
6. 
 

29. Tsartsalis D, Dragioti E, Kontoangelos K, 
Pitsavos C, Sakkas P, Papadimitriou GN, 
Stefanadis C, Kallikazaros I. The impact of 
depression and cardiophobia on quality 
of life in patients with essential 
hypertension. Psychiatriki 2016; 27(3):192-
203. 
 

30. Al-Atram AA. A review of the bidirectional 
relationship between psychiatric 
disorders and diabetes mellitus. 
Neurosciences Journal 2018; 23(2):91-96. 
 

31. Kruse J, Petrak F, Herpertz S, Albus C, 
Lange K, Kulzer B. Diabetes and 
depression--a life-endangering 



SEEMEDJ 2022, Vol 6, No 2 Somatic Illnesses and Mental Disorders Treatment 

66 Southeastern European Medical Journal, 2022; 6(2) 
 

interaction. Z Psychosom Med 
Psychother 2006; 52(3):289-309. 
 

32. Wiglusz MS, Landowski J, Cubała WJ. 
Prevalence of anxiety disorders in 
epilepsy. Epilepsy Behav 2018; 79:1-3.

 

 Author contribution. Acquisition of data: RM, AL, DD, TB 
Administrative, technical or logistic support: RM, AL, DD, TB 
Analysis and interpretation of data: RM, AL, DD, TB 
Conception and design: RM, AL, DD, TB 
Critical revision of the article for important intellectual 
content: RM, AL, DD, TB 

Drafting of the article: RM, AL, DD, TB 
Final approval of the article: RM, AL, DD, TB 
Guarantor of the study: RM, AL, DD, TB 
Obtaining funding: RM, AL, DD, TB 
Provision of study materials or patients: RM, AL, DD, TB 
Statistical expertise: RM, AL, DD, TB 
Other: RM, AL, DD, TB